Document Detail


Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications.
MedLine Citation:
PMID:  11074137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Homocysteine results from the transmethylation of methionine. Its metabolism depends primarily on three enzymes and several vitamin cofactors. Genetic abnormality in these enzymes or deficiency of these vitamins lead to hyperhomocysteinemia (HHCh). HHCh is usually biologically defined by a fasting value >15 micromol/l. HHCh belongs among the congenital hypercoagulable states and is a long-known vascular disease risk factor. The discovery that HHCh may also be responsible for several pregnancy complications has only recently been made. Studies in this area are still scarce and report on limited numbers of patients. It nevertheless appears clear that HHCh is associated with the syndromes of repeated miscarriage, pre-eclampsia, placenta abruptio, thromboembolic events, neural tube defects, and perhaps with fetal death-in-utero and intra-uterine growth retardation. Supplementation with vitamin B9 can reduce plasma HC levels, and is thus recommended in patients with HHCh. The prevention of thromboembolic events during pregnancy by anticoagulant treatment is also desirable in these patients.
Authors:
Y Aubard; N Darodes; M Cantaloube
Related Documents :
11506257 - Severe preeclampsia in antithrombin iii deficiency with no history of venous thromboemb...
13677267 - Pregnancy-associated thrombosis.
16962917 - Monitoring the effects and managing the side effects of anticoagulation during pregnancy.
20685557 - Thromboprophylaxis in pregnancy: who and how?
23377157 - Acute liver failure in an obstetric patient: challenge of critical care for 1 patient w...
17197597 - Maternal serum cytokines in preterm premature rupture of membranes.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  93     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-01-04     Completed Date:  2001-01-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  157-65     Citation Subset:  IM    
Affiliation:
Division of Obstetrics and Gynecology, CHU Dupuytren 2 av. Martin-Luther-King 87042 Limoges, Cedex, France. yaubard@compuserve.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / etiology
Anticoagulants / therapeutic use
Female
Fetal Death / etiology
Fetal Growth Retardation / etiology
Homocysteine / blood*
Humans
Neural Tube Defects / etiology
Pre-Eclampsia / etiology
Pregnancy
Pregnancy Complications / blood,  therapy*
Venous Thrombosis / etiology
Chemical
Reg. No./Substance:
0/Anticoagulants; 454-28-4/Homocysteine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France.
Next Document:  Plasminogen, alpha(2)-antiplasmin and complexes of plasmin-alpha(2)-antiplasmin (PAP) in amniotic fl...